GSK126 for cell activation

A potent, highly selective, S-adenosyl-methionine(SAM)-competitive, small-molecule inhibitor of EZH2 methyltransferase activity. GSK126 is highly selective against other methyltransferases and multiple other protein classes, even 150-fold more selective for the closest EZH1 (Kiapp = 89 nM) and more than 1,000-fold selective for 20 other human methyltransferases, including both SET-domain-containing and non-SET domain-containing methyltransferases. It decreases global H3K27me3 levels and reactivates silenced polycomb repressive complex 2 (PRC2) target genes.

No

1346574-57-9

526.67

Biochemicals

(S)-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide

C₃₁H₃₈N₆O₂

Crystalline solid

N/A

No

Yes

100% by chiral HPLC & >99% by HPLC

DMSO (~50 mg/ml)

-20 ̊C

gel pack

36 months

Protect from light and moisture

cell

For cells, cell lines and tissues in culture till half confluency.